Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
to join our faculty in Ann Arbor, MI. Successful candidate will focus on advancing DALTAC technology; selective proximity=inducing degraders that simultaneously inactivate AR and p300/CBP as a therapeutic
-
% - Ultrasound Data Collection and Data Analysis 30%-Conference Abstract and Manuscript Preparation Required Qualifications* PhD in Mechanical Engineering, Electrical Engineering, Computer Science, or related
-
tissue engineering approaches. The ideal candidate will have comprehensive knowledge and strong interest in pursuing musculoskeletal biology and/or microphysiological systems, with a willingness and track
-
, establish new research areas, and seek future funding opportunities from DARPA, ARPA-E and industry sources. Required Qualifications* PhD in Mechanical Engineering or related field. Experience conducting
-
approaches, our goal is to elucidate the molecular mechanisms underlying RAN translation and its contribution to neurodegeneration. Mission Statement Michigan Medicine improves the health of patients
-
of Orthopaedic Surgery is conducted by a diverse group of faculty, staff and trainees with expertise in biology, engineering, health outcomes, and healthcare. Our research teams are focused on improving treatment
-
excellence in education, patient care, community service, research and technology development, and through leadership activities in Michigan, nationally and internationally. Our mission is guided by our
-
: Engineering and curating data and knowledge artifacts such as decision-support systems, dashboards, audit + alert mechanisms, and learning loop tools to embed insights into clinical workflows. Project & Team
-
ranges from reprogramming intracellular signaling of cells to modeling whole joint mechanics to understand and modify these systems at their respective length scales. Our research focuses on engineering
-
of our lab is to identify and study novel molecular mechanisms that regulate T cell fate decisions with the ultimate goal of improving T cell-based immunotherapies. We use multiple modalities